The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: A systematic review and economic evaluation

Health Technology Assessment

Volumn 12, Issue 25, 2008, Pages

  Carlton, J ^a   Karnon, J ^a   Czoski Murray, C ^a   Smith, K J ^a   Marr, J ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CYCLOPLEGIC AGENT; LONG ACTING DRUG;

AGE DISTRIBUTION; AMBLYOPIA; ANISOMETROPIA; ASTIGMATISM; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; EYE REFRACTION; HEALTH ECONOMICS; HUMAN; MEDICAL LITERATURE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREDICTION; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REFRACTION ERROR; RETINOSCOPY; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STRABISMUS; SYSTEMATIC REVIEW; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; COST BENEFIT ANALYSIS; ECONOMICS; METHODOLOGY; PRESCHOOL CHILD; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); VISION TEST;

AMBLYOPIA; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; HUMANS; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STRABISMUS; VISION SCREENING;

EID: 48349106204     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta12250     Document Type: Review

References (181)

1. Snowdon SK, Stewart-Brown SL. Preschool vision screening. Health Technol Assess 1997;1(8).
2. Kleinstein RN, Jones LA, Hullett S, Kwon S, Lee RJ, Friedman NE, et al. Refractive error and ethnicity in children. Arch Ophthalmol 2003;121:1141-7.
3. National Screening Committee. NSC Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. National Screening Committee; 2003. URL: www.nsc.nhs.uk/pdfs/Criteria.pdf
4. Garber AM, Wieinstein MC, Torrance GW, Kamlet MS. Cost-effectiveness in health and medicine. Oxford: Oxford University Press; 1996.
5. Gold MR, Siegel JE, Russell LB, Weinstein MC. Theoretical foundations of cost-effectiveness analysis. In Garber AM, Weinstein MC, Torrance GW, Kamlet MS, editors. Cost-effectiveness in health and medicine. Oxford: Oxford University Press; 1996. Chapter 2, pp. 25-53.
6. Policy statement: eye examination in infants, children, and young adults by pediatricians. Pediatrics 2003;111:902-7.
7. Simons K. Preschool vision screening: rationale, methodology and outcome. Surv Ophthalmol 1996;41:3-30.
8. Simons K. Amblyopia characterization, treatment, and prophylaxis. Surv Ophthalmol 2005;50:123-66.
9. Kemper A, Harris R, Lieu TA, Homer CJ, Whitener BL. Screening for visual impairment in children younger than age 5 years: a systematic evidence review for the US Preventive Services Task Force (Provisional record). Rockville: US Preventive Services Task Force, 2004. p. 55.
10. Powell C, Wedner S, Richardson S. Screening for correctable visual acuity deficits in school-age children and adolescents. Cochrane Database Syst Rev 2004;(4):1-14.
11. Flom MC, Neumaier RW. Prevalence of amblyopia. Public Health Rep 1966;81:329-41.
12. Hopkisson B, Clarke JR, Oelman BJ. Residual amblyopia in recruits to the British Army. BMJ 1982;285:940.
13. Stewart-Brown S, Butler N. Visual acuity in a national sample of 10 year old children. J Epidemiol Commun Health 1985;39:107-12.
14. Newman DK, East MM. Prevalence of amblyopia among defaulters of preschool vision screening. Ophthalmic Epidemiol 2000; 7:67-71.
15. Graham PA. Epidemiology of strabismus. Br J Ophthalmol 1974; 58:224-31.
16. Stidwill D. Epidemiology of strabismus. Ophthalmic Physiol Opt 1997;17:536-9.
17. Bruce A, Hurst M, Abbott H, Harrison H. The incidence of refractive error and anomalies of binocular vision in infants. Br Orthoptic J 1991;48: 32-5.
18. McNeil J. Patterns of visual defects in children. BMJ 1955; 39:688-701.
19. Cole RBW. The problem of unilateral amblyopia. BMJ 1959; 1:202-6.
20. da Cunha D, Jenkins EM. Amblyopia in three year olds. Med Officer 1961;106:146-8.
21. Theodore FH, Johnson RM, Miles NE, Bonser WH. Causes of impaired vision in recently inducted soldiers. Arch Ophthalmol 1944;31: 399-402.
22. Downing AH. Ocular defects in 60,000 selectees. Arch Ophthalmol 1945;33:137-45.
23. Glover LP, Brewer WR. Ophthalmologic review of more than 20,000 men at the Altoona induction center. Am Ophthalmol 1944;27:346-8.
24. Agaston H. Ocular malingering. Arch Ophthalmol 1944; 31:223-31.
25. Helveston EM. The incidence of amblyopia ex anopsia in young adult males in Minnesota in 1962-63. Am Ophthalmol 1965;60:75-7.
26. Cholst MR, Cohen JJ, Losty MA. Evaluation of amblyopia problem in the child. NY Med J 1962;62:3927-30.
27. de Rotth A. Statistical analysis of 1,000 consecutive new eye patients. Am J Ophthalmol 1945;28: 1329-34.
28. Russell FL, Kada JM, Hufhines DM. Orange County vision screening project, part 2. Ophthalmological evaluation. Sight-Saving Rev 1965;31:215-19.
29. Vaughan D, Cook R, Bock R. Eye test for preschool and school age children. Stockton, CA: California Medical Eye Council; 1960.
30. Alberman ED, Butler NR, Sheridan MD. Visual acuity of a national sample (1958 cohort) at 7 years. Dev Med Child Neurol 1971; 13:9-14.
31. Commission for Racial Equality. Ethnic minorities in Great Britain. 2007. URL: http://www.cre.gov.uk/downloads/ factfile02_ethnic_minorities.pdf
32. MacEwen CJ, Chakrabarti HS. Why is squint surgery in children in decline? Br Ophthalmol 2004;88:509-11.
33. Arora A, Williams B, Arora AK, McNamara R, Yates J, Fielder A. Decreasing strabismus surgery. Br J Ophthalmol 2005;89:412.
34. Dobson V, Fulton AB, Sebris SL. Cycloplegic refractions of infants and young children: the axis of astigmatism. Invest Ophthalmol Vis Sci 1984;25: 83-7.
35. Gwiazda J, Thorn F, Bauer J, Held R. Emmetropization and the progression of manifest refraction in children followed from infancy to puberty. Clin Vis Sci 1993;8:337-44.
36. Gwiazda J, Scheiman M, Mohindra I, Held R. Astigmatism in children: changes in axis and amount from birth to six years. Invest Ophthalmol Vis Sci 1984;25:88-92.
37. Abrahamsson M, Fabian G, Andersson AK, Sjostrand J. A longitudinal study of a population based sample of astigmatic children. I. Refraction and amblyopia. Acta Ophthalmol 1990;68:428-34.
38. Abrahamsson M, Fabian G, Sjostrand J. A longitudinal study of a population based sample of astigmatic children. II. The changeability of anisometropia. Acta Ophthalmol 1990;68:435-40.
39. Dobson V, Sebris SL. Longitudinal study of acuity and stereopsis in infants with or at-risk for esotropia. Invest Ophthalmol Vis Sci 1989;30:1146-58.
40. Townshend AM, Holmes JM, Evans LS. Depth of anisometropic amblyopia and difference in refraction. Am Ophthalmol 1993;116:431-6.
41. Donahue SP. The relationship between anisometropia, patient age, and the development of amblyopia. Trans Am Ophthalmol Soc 2005; 103:313-36.
42. Ingram RM, Gill LE, Goldacre MJ. Emmetropisation and accommodation in hypermetropic children before they show signs of squint - a preliminary analysis. Bull Soc Belge Ophtalmol 1994;253:41-56.
43. Abrahamsson M, Sjostrand J. Natural history of infantile anisometropia. Br J Ophthalmol 1996;80:860-3.
44. Ingram RM, Walker C, Wilson JM, Arnold PE, Daily S. Prediction of amblyopia and squint by means of refraction at age 1 year. Br Ophthalmol 1986;70:12-15.
45. Rahi J, Logan S, Timms C, Russell-Eggitt I, Taylor D. Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study. Lancet 2002;360:597-602.
46. Tommila V, Tarkkanen A. Incidence of loss of vision in the healthy eye in amblyopia. Br J Ophthalmol 1981;65:575-7.
47. Sorsby A. The incidence and causes of blindness in England and Wales 1963-68. With an appendix on services available for incipient blindness. Reports on Public Health and Medical Subjects, No. 128. London: Department of Health and Social Security; 1972.
48. Vereecken EP, Brabant P. Prognosis for vision in amblyopia after the loss of the good eye. Arch Ophthalmol 1987;102:220-4.
49. Rahi JS, Logan S, Borja MC, Timms C, Russell-Eggitt I, Taylor D. Prediction of improved vision in the amblyopic eye after visual loss in the non-amblyopic eye. Lancet 2002;360:621-2.
50. Kandel GL, Grattan PE, Bedell HE. Are the dominant eyes of amblyopes normal? Am J Optom Physiol Opt 1980;57:1-6.
51. Laws D, Noonan CP, Ward A, Chandna A. Binocular fixation pattern and visual acuity in children with strabismic ambiyopia. J Pediatr Ophthalmol Strabismus 2000;37:24-8.
52. Chew E, Remaley NA, Tamboli A, Zhao J, Podgon MJ, Klebanoff M. Risk factors for esotropia and exotropia. Arch Ophthalmol 1994; 112:1349-55.
53. Zipf RF. Binocular fixation pattern. Arch Ophthalmol 1976; 94:401-5.
54. Simmers AJ, Gray LS, Spowart K. Screening for amblyopia: a comparison of paediatric letter tests. Br J Ophthalmol 1997;81:465-9.
55. Newman DK, East MM. Preschool vision screening: negative predictive value for amblyopia. Br J Ophthalmol 1999;83:676-9.
56. Schmidt P, Maguire M, Dobson V, Quinn G, Ciner E, Cyert L, et al. Comparison of preschool vision screening tests as administered by licensed eye care professionals in the Vision In Preschoolers Study. Ophthalmology 2004;111:637-50.
57. Ying GS, Kulp MT, Maguire M, Ciner E, Cyert L, Schmidt P, et al. Sensitivity of screening tests for detecting vision in preschoolers-targeted vision disorders when specificity is 94%. Optom Vis Sci 2005;82:432-8.
58. Williams C, Harrad RA, Harvey I, Sparrow JM, ALSPAC Study Team. Screening for amblyopia in preschool children: results of a population-based, randomised controlled trial. Ophthalmic Epidemiol 2001;8:279-95.
59. Pott JW, Oosterveen DK, Van Hof-van Duin J. Screening for suppression in young children: the polaroid suppression test. J Pediatr Ophthalmol Strabismus 1998;35:216-22.
60. Pott JW, Kingma C, Verhoeff K, Grootendorst RJ, de Faber JT. The polaroid suppression test in a pediatric population with ophthalmologic disorders. J AAPOS 2003;7:137-41.
61. Morale SE, Jeffrey BG, Fawcett SL, Stager DR, Salomao SR, Berezovsky A, et al. Preschool Worth 4-Shape test: testability, reliability, and validity. J AAPOS 2002;6:247-51.
62. Ruttum MS, Nelson DB. Stereopsis testing to reduce overreferral in preschool vision screening. J Pediatr Ophthalmol Strabismus 1991;28:131-3.
63. Schmidt PP, Maguire MG, Moore B, Cyert L, Vision in Preschoolers Study Group. Testability of preschoolers on stereotests used to screen vision disorders. Optom Vis Sci 2003;80:753-7.
64. Kohl P, Samek M. Refractive error and preferential looking visual acuity in infants 12-24 months of age: year 2 of a longitudinal study. Am Optom Assoc 1988;59:686-90.
65. Kennedy R, Sheps SB, Bagaric D. Field trial of the Otago photoscreener. Can J Ophthalmol 1995;30: 193-7.
66. Ottar WL, Scott WE, Holgado SI. Photoscreening for amblyogenic factors. Pediatr Ophthalmol Strabismus 1995;32:289-95.
67. Donahue SP, Johnson TM, Ottar W, Scott WE. Sensitivity of photoscreening to detect high-magnitude amblyogenic factors. J AAPOS 2002; 6: 86-91.
68. Hatch SW, Tibbles CD, Mestito IR, Read R, Traveis L, Richman J. Validity and reliability of the MTI Photoscreener. Optom Vis Sci 1997; 74:859-64.
69. Cordonnier M, Dramaix M. Screening for refractive errors in children: accuracy of the hand held refractor Retinomax to screen for astigmatism. Br Ophthalmol 1999;83:157-61.
70. Cordonnier M, Kallay O. Non-cycloplegic screening for refractive errors in children with the hand-held autorefractor Retinomax: final results and comparison with non-cycloplegic photoscreening. Strabismus 2001;9:59-70.
71. Barry JC, Konig HH. Non-cycloplegic screening for amblyopia via refractive findings with the Nikon Retinomax hand held autorefractor in 3 year old kindergarten children. Br J Ophthalmol 2001; 85:1179-82.
72. Williams C, Lumb R, Harvey I, Sparrow JM. Screening for refractive errors with the Topcon PR2000 Pediatric Refractometer. Invest Ophthalmol Vis Sci 2000;41:1031-7.
73. Allen SM. The effectivity of screening a comparative study of visual screening. Br Orthoptic J 1990;47:57-60.
74. Jarvis SN, Tamhne RC, Thompson L, Francis PM, Anderson J, Colver AF. Preschool vision screening. Arch Dis Child 1991;66:288-94.
75. Allen JW, Bose B. An audit of preschool vision screening. Arch Dis Child 1992;67:1292-3.
76. De Becker I, MacPherson HJ, LaRoche GR, Braunstein J, Cottle R, McIntyre LL, et al. Negative predictive value of a population-based preschool vision screening program. Ophthalmology 1992; 99:998-1003.
77. Williamson TH, Andrews R, Dutton GN, Murray G, Graham N. Assessment of an inner city visual screening programme for preschool children. Br J Ophthalmol 1995;79:1068-73.
78. McNamara R, Duckworth S. The effect of removing vision testing from child surveillance programmes. Br Orthoptic J 1998; 66:26-31.
79. Robinson B, Bobier WR, Martin E, Bryant L. Measurement of the validity of a preschool vision screening program. Am Public Health 1999; 89: 193-8.
80. Mulley L. The Airedale Vision Screening Programme: a comparison of referral rates between two preschool age groups. Br Orthoptic J 2000;57:39-41.
81. Eibschitz-Tsimhoni M, Friedman T, Naor J, Eibschitz N, Friedman Z. Early screening for amblyogenic risk factors lowers the prevalence and severity of amblyopia. J AAPOS 2000;4:194-9.
82. Juttmann R, Rotterdam AMblyopia Screening Effectiveness Study (RAMSES) Steering Committee. The Rotterdam AMblyopia Screening Effectiveness Study (RAMSES): compliance and predictive value in the first 2 years. Br J Ophthalmol 2001;85:1332-5.
83. Barry JC, Konig HH. Test characteristics of orthoptic screening examination in 3 year old kindergarten children. Br J Ophthalmol 2003;87:909-16.
84. Chui L, Fraser T, Hoar K, LaRoche GR. Negative predictive value of a vision screening program aimed at children aged 3 to 4 years old. J AAPOS 2004;8:566-70.
85. Rosner J, Rosner J. Parents as screeners for strabismus in their children. J Vis Impairment Blindness 1988;82:193-4.
86. Paysse EA, Camejo L, Hussein MA, Coats DK. Parent-administered visual acuity testing: is it reliable and can it improve office efficiency? J AAPOS 2004;8:332-7.
87. The Vision in Preschoolers Study Group. Preschool vision screening tests administered by nurse screeners compared with lay screeners in the vision in preschoolers study. Invest Ophthalmol Vis Sci 2005; 46:2639-48.
88. Edwards RS, Whitelaw AJ, Abbott AG. Orthoptists as pre-school screeners: a 2-year study. Br Orthoptic J 1989;46:14-19.
89. Bolger PG, Stewart-Brown SL, Newcombe E, Starbuck A. Vision screening in preschool children: comparison of orthoptists and clinical medical officers as primary screeners. BMJ 1991;303: 1291-4.
90. Bray LC, Clarke MP, Jarvis SN, Francis PM, Colver A. Preschool vision screening: a prospective comparative evaluation. Eye 1996; 10:714-18.
91. Kohler L, Stigmar G. Visual disorders in 7-year-old children with and without previous vision screening. Acta Paediatr Scand 1978; 67:373-7.
92. Edwards RS, Abbott AG, Whitelaw AJ. The outcome of pre-school visual screening. Br Orthoptic J 1993;50:2-6.
93. Newman DK, Hitchcock A, McCarthy H, Keast-Butler J, Moore AT. Preschool vision screening: outcome of children referred to the hospital eye service. Br Ophthalmol 1996;80: 1077-82.
94. Harrad RA, Williams C, Sparrow JM, Northstone K, Harvey I. Visual acuity at 7 years after orthoptic screening at different ages - results of a randomised controlled trial. Invest Ophthalmol Vis Sci 2002; 43:e-Abstract 2941.
95. Williams C, Northstone K, Harrad RA, Sparrow JM, Harvey I, ALSPAC Study Team. Amblyopia treatment outcomes after screening before or at age 3 years: follow up from randomised trial. BMJ 2002;324:1549.
96. Williams C, Northstone K, Harrad RA, Sparrow JM, Harvey I. Amblyopia treatment outcomes after preschool screening v school entry screening: observational data from a prospective cohort study. Br J Ophthalmol 2003;87:988-93.
97. Bui CM, Donahue SP. Long-term follow-up of patients with amblyopia initially identified by preschool photoscreening. Invest Ophthalmol Vis Sci 2006;47:e-Abstract 2936.
98. Hall DMB, Elliman D. Health for all children. 4th ed. 2003.
99. National Screening Committee. Vision screening in children under five years old. Child Health Sub-Group Report on Vision Screening. London: National Screening Committee; 2005. URL: www.library.nhs.uk/ SpecialistLibrarySearch/Download.aspx?resID=88202
100. Hall DMB, Stewart-Brown K. Screening in child health. Br Med Bull 1998;54:929-43.
101. Department of Health, Social Services and Public Safety. Health for all children: guidance and principles of practice for professional staff. Department of Health; 2006 URL: http://www.dhsspsni.gov.uk/ guidance_and_principles_of_practice_for_professional_staff_ health_for_all_children.pdf
102. Stewart CE. LogMAR-based visual acuity measurements: limits of normality. Br Ir Orthoptic J 2006;3:9-13.
103. Jones D, Westall C, Averheck K, Abdolell M. Visual acuity assessment: a comparison of two tests for measuring children's vision. Ophthalmic Physiol Opt 2003;23:541-6.
104. Stewart C. Comparison of Snellen and log-based acuity scores for school-aged children. Br Orthoptic J 2000;57:32-8.
105. Shea SJ, Gaccon L. In the absence of strabismus what constitutes a visual deficit in children? Br J Ophthalmol 2006;90:40-3.
106. Royal College of Ophthalmologists. Ophthalmic services for children. Royal Society of Health Journal; 2005. URL: http://rcophth.ac.uk/docs/profstands/ophthalmicservices/ OphthalmicServicesforChildrenMay2005.pdf
107. Epelbaum M, Milleret C, Buisseret P, Dufier JL. The sensitive period for strabismic amblyopia in humans. Ophthalmology 1993; 100:323-7.
108. Stewart CE, Fielder AR, Moseley MJ, Stephens DA. Visual function of children with amblyopia during refractive adaptation and occlusion therapy. Invest Ophthalmol Vis Sci 2003;44:e-Abstract 4245.
109. Stewart CE, Moseley MJ, Stephens DA, Fielder AR, on behalf of the MOTAS Cooperative. Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol 2005; 88:1552-6.
110. Repka MX, Beck RW, Holmes JM, Birch EE, Chandler DL, Cotter SA, et al. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 2003;121:603-11.
111. Elliott S. A national survey to assess the prevalence of written guidance for occlusion and practice variation in the treatment of amblyopia. Br Orthoptic J 2005;2:26-31.
112. Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with patching in children: experience of the amblyopia treatment study. Am J Ophthalmol 2003;136: 620-9.
113. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002;120:268-78.
114. Repka MX, Cotter SA, Beck RW, Kraker RT, Birch EE, Everett DF, et al. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology 2004;111: 2076-85.
115. Holmes JM, Kraker RT, Beck RW, Birch EE, Cotter SA, Everett DF, et al. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 2003; 110:2075-87.
116. Foley-Nolan A, McCann A, OKeefe M. Atropine penalisation versus occlusion as the primary treatment for amblyopia. Br Ophthalmol 1997;81:54-7.
117. Stewart CE, Fielder AR, Moseley MJ, Stephens DA, MOTAS. Dose-response relationship for occlusion therapy for the treatment of amblyopia: initial results from the MOTAS study. Invest Ophthalmol Vis Sci 2002;43:e-Abstract 2939.
118. Stewart CE, Moseley MJ, Stephens DA, Fielder AR, on behalf of the MOTAS Cooperative. The treatment dose response in amblyopia therapy: results from the monitored occlusion treatment of amblyopia study (MOTAS). Invest Ophthalmol Vis Sci 2005;45:3048-54.
119. Stewart CE, Moseley MJ, Fielder AR, Stephens DA. Optimization of the dose-response of occlusion therapy for amblyopia: the ROTAS study. Invest Ophthalmol Vis Sci 2004;45:e-Abstract 2579.
120. Stewart CE, Moseley MJ, Stephens DA, Fielder AR. Modelling of treatment dose-response in amblyopia. Invest Ophthalmol Vis Sci 2005; 46: e-Abstract 3595.
121. Clarke MP, Wright CM, Hrisos S, Anderson JD, Henderson J, Richardson SR. Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening. BMJ 2003;327:1251.
122. Levartovsky S, Oliver M, Gottesman N, Shimshoni M. Factors affecting long term results of successfully treated amblyopia: initial visual acuity and type of amblyopia. Br J Ophthalmol 1995; 79:225-8.
123. Woodruff G, Hiscox F, Thompson JR, Smith LK. Factors affecting the outcome of children treated for amblyopia. Eye 1994; 8:627-31.
124. Levartovsky S, Oliver M, Gottesman N, Shimshoni M. Long-term effect of hypermetropic anisometropia on the visual acuity of treated amblyopic eyes. Br J Ophthalmol 1998;82:55-8.
125. Fitzgerald DE, Krumholtz I. Maintenance of improvement gains in refractive amblyopia: a comparison of treatment modalities. Optometry 2002;73:153-9.
126. Holmes JM, Beck RW, Kraker RT, Astle WF, Birch EE, Cole SR, et al. Risk of amblyopia recurrence after cessation of treatment. J AAPOS 2004;8:420-8.
127. Awan M, Proudlock FA, Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci 2005;46: 1435-9.
128. Hussein MAW, Coats DK, Muthialu A, Cohen E, Paysse EA. Risk factors for treatment failure of anisometropic amblyopia. J AAPOS 2004; 8: 429-34.
129. Scott WE, Kutschke PJ, Keech RV, Pfeifer WL, Nichols B, Zhang L. Amblyopia treatment outcomes. J AAPOS 2005;9:107-11.
130. Levartovsky S, Gottesman N, Shimshoni M, Oliver M. Factors affecting long-term results of successfully treated amblyopia: age at beginning of treatment and age at cessation of monitoring. J Pediatr Ophthalmol Strabismus 1992;29:219-23.
131. Cobb CJ, Russell K, Cox A, MacEwen CJ. Factors influencing visual outcome in anisometropic amblyopes. Br J Ophthalmol 2002; 86:1278-81.
132. Smith LK, Thompson JR, Woodruff G, Hiscox F. Factors affecting treatment compliance in amblyopia. J Pediatr Ophthalmol Strabismus 1995; 32:98-101.
133. Newsham D. Parental non-concordance with occlusion therapy. Br J Ophthalmol 2000;84: 957-62.
134. Newsham D. A randomised controlled trial of written information: the effect on parental nonconcordance with occlusion therapy. Br Ophthalmol 2002;86:787-91.
135. Dixon-Woods M, Awan M, Gottlob I. Why is compliance with occlusion therapy for amblyopia so hard? A qualitative study. Arch Dis Child 2006;91:491-4.
136. Spencer RF, Tucker MG, Choi RY, McNeer KW. Botulinum toxin management of childhood intermittent exotropia. Ophthalmology 1997; 104:1762-7.
137. Rutstein RP, Marsh-Tootle W. Clinical course of accommodative esotropia. Optometry Vis Sci 1998;75:97-102.
138. Ing MR, Okino LM. Outcome study of stereopsis in relation to duration of misalignment in congenital esotropia. J AAPOS 2002;6:3-8.
139. Paysse EA. Photorefractive keratectomy for anisometropic amblyopia in children. Trans Am Ophthalmol Soc 2004;102:341-72.
140. Drack AV, Nucci P. Refractive surgery in children. Ophthalmol Clin North Am 2001;14:457-66.
141. Hutchinson AK. Pediatric refractive surgery. Curr Opin Ophthalmol 2003;14:267-75.
142. Stewart CE, Fielder AR, Stephens DA, Moseley MJ, on behalf of the MOTAS Cooperative. Treatment of unilateral amblyopia: factors influencing visual outcome. Invest Ophthalmol Vis Sci 2005;46: 3152-60.
143. Packwood EA, Cruz OA, Rychwalski PJ, Keech RV. The psychosocial effects of amblyopia study. J AAPOS 1999;3:15-7.
144. van de Graaf ES, van der Sterre GW, Polling JR, van KH, Simonsz B, Simonsz HJ. Amblyopia & Strabismus Questionnaire: design and initial validation. Strabismus 2004;12:181-93.
145. Parkes LC. An investigation of the impact of occlusion therapy on children with amblyopia, its effect on their families, and compliance with treatment. Br Orthoptic J 2001;58:30-7.
146. Searle A, Norman P, Harrad R, Vedhara K. Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children. Eye 2002;16:150-5.
147. Choong YF, Lukman H, Martin S, Laws DE. Childhood amblyopia treatment: psychosocial implications for patients and primary carers. Eye 2004;18:369-75.
148. Horwood J, Waylen A, Herrick D, Williams C, Wolke D. Common visual defects and peer victimization in children. Invest Ophthalmol Vis Sci 2005;46:1177-81.
149. Williams C, Horwood J, Northstone K, Herrick D, Waylen A, Wolke D, et al. The timing of patching treatment and a child's well-being. Br J Ophthalmol 2006;90:670-1.
150. Rahi JS, Cumberland P, Peckham CS. Does amblyopia affect educational, health and social outcomes? Findings from 1958 British birth cohort. BMJ 2006;332:820-5.
151. Chua B, Mitchell P. Consequences of amblyopia or education, occupation, and long term vision loss. Br J Ophthalmol 2004;88:1119-21.
152. Hrisos S, Clarke MP, Kelly T, Henderson J, Wright CM. Unilateral visual impairment and neuro-developmental performance in pre-school children. Br J Ophthalmol 2006;90:836-8.
153. Satterfield D, Keltner JL, Morrison TL. Psychosocial aspects of strabismus study. Arch Ophthalmol 1993;111:1100-5.
154. Archer SM, Musch DC, Wren PA, Guire KE, Del Monte MA. Social and emotional impact of strabismus surgery on quality of life in children. J AAPOS 2005;9:148-51.
155. Theunissen NCM, Vogels GC, Koopman HM, Verrips GHW, Zwinderman HAH, Verloove-Vanhorick SP, et al. The proxy problem: child report versus parent report in health related quality of life reserach. Qual Life Res 1998;7:387-97.
156. Curtis L, Netten A. Unit costs of health and social care. London: Personal Social Services Research Unit; 2005. URL: www.pssru.ac.uk/pdf/ uc/uc2005/uc2005.pdf
157. Moss SM, Gray A, Legood R, Henstock F. Evaluation of HPV/LPC cervical cancer screening pilot studies. First report to the Department of Health on evaluation of LBC. London: National Health Service; 2002. URL: www.cancerscreening.nhs.uk/cervical/lbc-pilot-evaluation.pdf
158. Roderick P, Davies R, Rafferty J, Crabbe D, Pearce R, Bhandari P, et al. The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation. Health Technol Assess 2003;7(6).
159. Konig HH, Barry JC, Leidl R, Zrenner E. Cost-effectiveness of orthoptic screening in kindergarten: a decision-analytic model. Strabismus 2000;8:79-90.
160. Konig HH, Walter HS, Barry JC. Resource utilisation and cost of amblyopia treatment. Klin Monatsbl Augenheilkd 2003; 220:486-91.
161. Konig HH, Barry JC. Cost effectiveness of treatment for amblyopia: an analysis based on a probabilistic Markov model. Br J Ophthalmol 2004;88:606-12.
162. Konig HH, Barry JC, Leidl R, Zrenner E. Economic evaluation of orthoptic screening: results of a field study in 121 German kindergartens. Invest Ophthalmol Vis Sci 2002;43: 3209-15.
163. Konig H, Barry J. Economic evaluation of different methods of screening for amblyopia in kindergarten. Pediatrics 2002;109:e59.
164. Barry JC, Hartmann A, Pongs UM, Jockel M. Model for cost-benefit relations of amblyopia screening. Ophthalmologe 1998; 95:19-27.
165. Konig HH, Barry JC. Cost-utility analysis of orthoptic screening in kindergarten: a Markov model based on data from Germany. Pediatrics 2004;113:95-108.
166. Gandjour A, Schlichtherle S, Neugebauer A, Russmann W, Lauterbach KW. A cost-effectiveness model of screening strategies for amblyopia and risk factors and its application in a German setting. Optometry Vis Sci 2003;80:259-69.
167. Neubauer AS, Neubauer S. Cost-effectiveness of screening for amblyopia. Klin Monatsbl Augenheilkd 2005;222:110-16.
168. Joish VN. A cost-benefit analysis of vision screening methods for preschoolers and school age children. J AAPOS, 2003; 7:283-90.
169. Arnold RW, Armitage MD, Gionet EG, Balinger A, Kovtoun TA, Machida C, et al. The cost and yield of photoscreening: impact of photoscreening on overall pediatric ophthalmic costs. Pediatr Ophthalmol Strabismus 2005;42:103-11.
170. Brown MM, Brown GC, Sharma S, Busbee B, Brown H. Quality of life associated with unilateral and bilateral good vision. Ophthalmology 2001;108:643-8.
171. Rubin GS, Munoz B, Bandeen-Roche K, West SK. Monocular versus binocular visual acuity as measures of vision impairment and predictors of visual disability. Invest Ophthalmol Vis Sci 2000;41:3327-34.
172. Brown GC, Sharma S, Brown MM, Kistler J. Utility values and age-related macular degeneration. Arch Ophthalmol 2000;118:47-51.
173. Espallargues M, Czoski-Murray CJ, Bansback NJ, Canton J, Lewis GM, Hughes LA, et al. The impact of age-related macular degeneration on health status utility values. Invest Ophthalmol Vis Sci 2005; 46:4016-23.
174. Meads C, Moore D. The clinical effectiveness and cost utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess 2001;7(9).
175. Ethical Strategies Ltd. An analysis of the costs of visual impairment and blindness in the United Kingdom. Ethical Strategies; 2003. URL: www.healthyeyes.org.uk/fileadmin/healthy-eyes/downloads/ cost-of-blindness.doc
176. Chilcott J, Brennan A, Booth A, Karnon J, Tappenden P. The role of modelling in prioritising and planning clinical trials. Health Technol Assess 2003;7(23).
177. Population Estimates Unit. Age structure of England and Wales. London: Office of National Statistics; 2006. URL: http://statistics.gov.uk/populationestimates/svg_pyramid/default.htm
178. Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, et al. Principles of good practice for decision analytic modelling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices - Modelling Studies. Value Health 2003; 6:9-17.
179. Goldhaber-Fiebert JD, Stout NK, Ortendahl J, Goldie SJ. HPV DNA testing, prophylactic HPV vaccination and current US cervical cancer screening guidelines: a cost-effectiveness analysis. 2006.
180. Karlsson G, Johannesson M. The decision rules of cost-effectiveness analysis. Pharmacoeconomics 1996;9:113-20.
181. Towse A, Pritchard C, Devlin N. Cost-effectiveness thresholds: economic and ethical issues. Office of Health Economics; 2002.